
Last update at 2026-06-04T15:35:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Income before tax | -85.50000M | -106.80000M | -41.20000M | 283.90M | 20.30M |
| Minority interest | -3.30000M | -0.20000M | -0.50000M | -1.30000M | 13.10M |
| Net income | -72.60000M | -67.00000M | -25.90000M | 208.70M | -1.50000M |
| Selling general administrative | 115.20M | 92.10M | 91.50M | 133.80M | 125.30M |
| Selling and marketing expenses | 77.50M | 74.50M | 73.50M | 55.80M | 53.90M |
| Gross profit | 337.70M | 307.30M | 412.50M | 709.20M | 437.40M |
| Reconciled depreciation | 96.40M | 105.30M | 93.90M | 71.30M | 69.80M |
| Ebit | -13.40000M | -39.90000M | 6.20M | 308.50M | 58.40M |
| Ebitda | 83.00M | 113.40M | 100.10M | 387.00M | 117.20M |
| Depreciation and amortization | 96.40M | 153.30M | 93.90M | 78.50M | 58.80M |
| Non operating income net other | - | - | - | - | - |
| Operating income | -24.10000M | -35.40000M | 6.20M | 308.50M | 58.40M |
| Other operating expenses | 2010.90M | 2006.30M | 2267.90M | 1917.40M | 1486.70M |
| Interest expense | 72.10M | 75.10M | 47.40M | 31.80M | 27.10M |
| Tax provision | - | 13.10M | -15.30000M | 73.90M | 21.80M |
| Interest income | 12.10M | 10.20M | 1.60M | 1.00M | 1.20M |
| Net interest income | - | -64.90000M | -45.80000M | -30.80000M | -29.60000M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | -18.80000M | -4.50000M | -15.30000M | 73.90M | 21.80M |
| Total revenue | 1986.80M | 1970.90M | 2383.90M | 2329.50M | 1644.20M |
| Total operating expenses | 361.80M | 342.70M | 296.50M | 297.10M | 279.90M |
| Cost of revenue | 1649.10M | 1663.60M | 1971.40M | 1620.30M | 1206.80M |
| Total other income expense net | -61.40000M | -71.40000M | -47.40000M | -24.60000M | -38.10000M |
| Discontinued operations | - | - | -7.10000M | 11.00M | 11.00M |
| Net income from continuing ops | -66.70000M | -102.30000M | -25.90000M | 210.00M | -1.50000M |
| Net income applicable to common shares | - | - | -32.50000M | 208.70M | 3.10M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Total assets | 2537.20M | 2706.70M | 3047.60M | 2450.90M | 2059.10M |
| Intangible assets | 477.70M | 523.60M | 584.50M | 344.00M | 377.60M |
| Earning assets | - | - | - | - | - |
| Other current assets | 33.70M | 19.30M | 222.90M | 316.00M | 263.80M |
| Total liab | 1429.50M | 1544.70M | 2016.60M | 1417.90M | 1431.00M |
| Total stockholder equity | 1092.30M | 1148.60M | 1017.00M | 1019.30M | 615.00M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | 139.10M | 173.50M | 92.80M | 140.50M | 103.60M |
| Common stock | 1.60M | 1.60M | 46.70M | 46.70M | 42.50M |
| Capital stock | 1.60M | 1.60M | 46.70M | 46.70M | 42.50M |
| Retained earnings | 136.70M | 209.80M | 273.50M | 383.80M | 192.40M |
| Other liab | - | - | 164.90M | 200.20M | 274.30M |
| Good will | 455.10M | 465.70M | 480.80M | 487.00M | 493.40M |
| Other assets | - | 0.00000M | 56.20M | 29.20M | 23.80M |
| Cash | 225.80M | 371.30M | 227.70M | 505.30M | 201.80M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 555.10M | 488.10M | 582.70M | 563.50M | 468.40M |
| Current deferred revenue | - | 28.00M | - | - | - |
| Net debt | 652.90M | 555.00M | 1070.40M | 157.70M | 517.20M |
| Short term debt | 136.50M | 14.50M | 29.10M | 8.80M | 30.70M |
| Short long term debt | 124.20M | 0.70M | 18.50M | - | 20.10M |
| Short long term debt total | 878.70M | 926.30M | 1298.10M | 663.00M | 719.00M |
| Other stockholder equity | 925.90M | 925.90M | 696.80M | 588.80M | 380.10M |
| Property plant equipment | - | - | 753.60M | 508.30M | 521.80M |
| Total current assets | 826.10M | 950.90M | 1164.40M | 1075.00M | 635.90M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | - | - | -48.30000M | 188.30M | -256.00000M |
| Short term investments | - | 4.30M | - | - | - |
| Net receivables | 218.40M | 216.20M | 271.60M | 312.80M | 252.90M |
| Long term debt | 698.60M | 870.30M | 1234.10M | 619.50M | 643.90M |
| Inventory | 348.20M | 344.10M | 407.90M | 253.70M | 170.30M |
| Accounts payable | 261.90M | 272.10M | 460.80M | 414.20M | 334.10M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | 28.10M | 11.30M | - | - | - |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | 42.50M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 26.00M | 16.50M | 14.00M | 7.40M | 6.60M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 1711.10M | 1755.80M | 1883.20M | 1375.90M | 1423.20M |
| Capital lease obligations | 55.90M | 55.30M | 45.50M | 43.50M | 55.00M |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Investments | -61.70000M | 107.70M | -848.20000M | -78.60000M | -365.80000M |
| Change to liabilities | - | - | -115.60000M | 69.70M | -12.70000M |
| Total cashflows from investing activities | -61.70000M | 107.70M | -848.20000M | -78.60000M | -365.80000M |
| Net borrowings | -28.40000M | -343.60000M | 515.50M | -9.70000M | 289.30M |
| Total cash from financing activities | -45.90000M | -90.90000M | 414.50M | 118.50M | 273.20M |
| Change to operating activities | - | - | - | - | - |
| Net income | -25.90000M | 17.70M | -26.50000M | 308.50M | 58.40M |
| Change in cash | -145.10000M | 161.40M | -296.10000M | 314.00M | 87.70M |
| Begin period cash flow | 370.60M | 209.20M | 505.30M | 191.30M | 103.60M |
| End period cash flow | 225.50M | 370.60M | 209.20M | 505.30M | 191.30M |
| Total cash from operating activities | -33.50000M | 150.00M | 133.90M | 273.50M | 186.80M |
| Issuance of capital stock | -0.20000M | 265.10M | 1.50M | 202.20M | 0.20M |
| Depreciation | 96.40M | 105.30M | 93.90M | 71.30M | 69.80M |
| Other cashflows from investing activities | 8.40M | 1.90M | 1.90M | 1.90M | 1.90M |
| Dividends paid | - | - | 99.50M | 73.50M | 12.80M |
| Change to inventory | -15.50000M | 45.70M | -12.30000M | -87.70000M | 17.10M |
| Change to account receivables | -23.40000M | 52.70M | 147.00M | -64.80000M | 19.10M |
| Sale purchase of stock | -4.70000M | - | - | - | -0.20000M |
| Other cashflows from financing activities | -12.60000M | -12.40000M | 723.10M | -10.20000M | 1278.30M |
| Change to netincome | - | - | 53.40M | 76.30M | 90.40M |
| Capital expenditures | 90.60M | 84.00M | 90.80M | 82.20M | 53.80M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | -24.90000M | 80.60M | 19.10M | -82.80000M | 23.50M |
| Stock based compensation | 1.60M | 1.80M | 0.70M | 2.10M | 2.00M |
| Other non cash items | -80.70000M | -55.40000M | 46.70M | 142.40M | 131.20M |
| Free cash flow | -124.10000M | 66.00M | 43.10M | 191.30M | 133.00M |
Sector: Basic Materials Industry: Specialty Chemicals
| Company | Change (GBX) | Price (GBX) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| SYNT Synthomer plc |
-3.0 2.68% | 109.00 | - | 21.74 | 0.04 | 0.06 | 0.40 | 8.79 |
| CRDA Croda International PLC |
-11.0 0.37% | 2938.00 | 68.18 | 16.64 | 2.46 | 1.83 | 2.67 | 17.69 |
| JMAT Johnson Matthey PLC |
7.00 0.33% | 2142.00 | - | 9.44 | 0.29 | 1.53 | 0.36 | 10.76 |
| ELM Elementis PLC |
-1.6 1.05% | 151.20 | 19.70 | 15.15 | 1.50 | 1.79 | 2.27 | 9.68 |
| 87FZ AECI Ltd |
- -% | 0.66 | 0.01 | - | 0.02 | - |
Synthomer plc manufactures and supplies specialised polymers and ingredients for coatings, construction, adhesives, and health and protection sectors. The company offers adhesives, such as PSA labels, and packaging and specialty tapes; tape saturants, release coating, wood working, sealants, wet glues, hygiene, and contact adhesives; packaging and assembly hot melt adhesives; and liquid polybutadiene products under the LITHENE brand. It also provides architectural, intumescent, metal, and wood coating, as well as masonry, protective film, polyester for powder coating, and other products; coalescing agents and glycol/diol under SYNTHOMER NX and SYNOXOL BEPD brands; construction products comprising mortar modification and waterproofing product, construction adhesive, additives for construction, asphalt and road product, wire and cable, cement adhesive, assembly HMA, glass EIFS, polyester PES roofing, decorative laminates, flooring adhesives, and technical fibre products. In addition, the company offers building materials, industrial, hygiene, tyre and rubber, home textile, and consumer product; health and protection products, such as medical and examination gloves, industrial and fabric supported gloves, medical devices, personal care and food additives, hygiene adhesives, non-wovens, footwear, hygiene, and wipes; performance materials; well cementing and drilling fluid additives, and battery binders; tufted, woven, needlefelt, and automotive carpet; artificial turf, gel foam elastomer backings, footwear and bedding foam, specialty and graphic paper, and packaging board; and latex foam under Liponan Terra brand. It operates in the United Kingdom, Germany, Italy, the Netherlands, France, Belgium, Spain, other Europe, Malaysia, China, Other Asia, the United States, and internationally. The company was formerly known as Yule Catto & Co. plc and changed its name to Synthomer plc in 2012. Synthomer plc was founded in 1863 and is headquartered in London, the United Kingdom.
45 Pall Mall, London, United Kingdom, SW1Y 5JG
| Name | Title | Year Born |
|---|---|---|
| Mr. Michael Willome lic. oec. HSG | CEO & Exec. Director | 1966 |
| Ms. Lily Liu | CFO & Director | NA |
| Mr. Philip Wrigley | Pres of Operations & SHE | NA |
| Mr. Marshall D. Moore | CTO & Pres of Americas | 1964 |
| Mr. Anant Prakash | Chief Counsel & Company Sec. | NA |
| Mr. Tim Hughes | Pres of Corp. Devel. | NA |
| Ms. Alice L. M. Heezen-Dokianos | Chief HR Officer | 1971 |
| Mr. Richard Collier Atkinson | Exec. Officer | 1963 |
| Mr. Neil Whitley | Pres of Performance Elastomers Division, Asia, M&A and HR | NA |
| Mr. Rob Tupker M.B.A., M.Sc. | Pres of Functional Solutions & Europe | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.